Clinical research at risk

June 20, 2003

Innovative clinical research is at risk from heavy-handed bureaucratic European legislation that could cripple university hospital trials, says the Academy of Medical Sciences. The cost of non-commercial clinical research will soar if academic clinicians have to meet European Clinical Trial Directive regulations, due to become law in ten months. AMS members believe the UK did not do enough to fight the directive.

Please login or register to read this article

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments